Award Winners

The ISPOR Research Presentation Podium and Poster Awards were established in 1998 to recognize the scientific merit of podium and poster presentations of the ISPOR Annual International Meetings, Annual European Congresses, Asia-Pacific and Latin America Conferences.

This year, the ISPOR judges evaluated podium presentations and nominated poster presentations. All podium presentations are considered for an award. Poster presentations in the top 10%, based on abstract review score, are considered and eligible for a poster presentation award. 
Evaluations of scientific merit were based upon the following criteria:

  • Background provides appropriate perspective / context for the subject
  • Objectives / research questions are clearly stated
  • Research design / methods / modeling is appropriate and transparent (scores on this will determine winners in case of ties)
  • Data sources and/or sampling procedures are clear and appropriate
  • Data analyses are appropriate
  • Research objectives are met/addressed
  • Implications of findings are discussed
  • Factual information is kept separate from interpretations or implications
  • Abstract is presented in an unbiased manner
  • Clarity of presentation

THE RECIPIENTS ARE . . .

Best General Poster Research Presentations

PND10: ANTI-TNF-α INHIBITORS IN PREVENTING ALZHEIMER'S DISEASE (AD): A RETROSPECTIVE REVIEW USING BOTH EMR AND CLAIMS DATA
Presenting Author: Jennifer Stacey, TriNetX Inc., Cambridge, MA, USA

PCN203: HEALTH-CARE RESOURCE USE AND COSTS IN AML-PATIENTS UNDERGOING STEM CELL TRANSPLANTATION
Presenting Author: Josefine Redig, ICON Plc, Stockholm, AB, Sweden

PIH18: PREDICTED COST AND CAPACITY BENEFITS OF THE DIGITALIZED SECONDARY CARE PATH FOR WOMEN WITH ENDOMETRIOSIS @ VIRTUAL HOSPITAL 2.0
Presenting Author: Erkki Soini, ESiOR Oy, Kuopio, 15, Finland

Best Student Poster Research Presentations

PCN261: ESTIMATING THE NUMBER OF PATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE ACROSS EUROPE
Presenting Author: Tamas Agh, Syreon Research Institute, Budapest, Hungary

PMU77: OPIOID USE PATTERNS AND HEALTHCARE USE AMONG INDIVIDUALS WITH COMORBID CHRONIC NON-CANCER PAIN AND OBSTRUCTIVE SLEEP APNEA
Presenting Author: Aakash Bipin Gandhi, University of Maryland School of Pharmacy, Baltimore, MD, USA

PND45: OCRELIZUMAB IS A COST-EFFECTIVE OPTION FOR RELAPSING MULTIPLE SCLEROSIS PATIENTS, IN IRAN
Presenting Author: Nayyereh Ayati, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, 07, Iran

Best New Investigator Poster Research Presentations

PCV156: A MULTILEVEL ACCESS EVIDENCE FRAMEWORK FOR INNOVATIVE TECHNOLOGIES SPECIFIC TO HAEMATOLOGICAL MALIGNANCIES
Presenting Author: Katy Harrison, National Institute for Health and Care Excellence (NICE), UK

PIT10: THE INCREMENTAL COST OF TRAUMATIC BRAIN INJURY DURING THE FIRST YEAR AFTER A ROAD TRAFFIC ACCIDENT IN BELGIUM.
Presenting Author: Helena Van Deynse, Vrije Universiteit Brussel, Brussels, Belgium 

PSS24: INSERTABLE CARDIAC MONITOR (ICM) HEALTHCARE PATHWAYS OF PATIENTS WITH CARDIAC ARRHYTHMIAS BASED ON GERMAN STATUTORY HEALTH INSURANCE CLAIMS DATA
Presenting Author: Nikolaos Tsitiridis, BIOTRONIK SE Co. KG, Berlin, Germany

Best General Podium Research Presentations

CL4: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF THE EFFICACY AND TOLERABILITY OF APALUTAMIDE AND DAROLUTAMIDE FOR THE TREATMENT OF NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC)
Presenting Author: Suzy Van Sanden, Janssen EMEA, Beerse, Belgium

SP2: DISCREPANCY IN HEALTH STATE UTILITY VALUES BETWEEN COST-UTILITY ANALYSIS AND REFERENCED ORIGINAL HEALTH UTILITY STUDIES IN CARDIOVASCULAR DISEASE: A REGISTRY-BASED ANALYSIS
Presenting Author: Feng Xie, McMaster University, Hamilton, ON, Canada

CC1: COST-EFFECTIVENESS OF SCREENING AND TREATING CHILDREN WITH FAMILIAL HYPERCHOLESTEROLEMIA EARLY IN LIFE FROM A DUTCH HEALTHCARE PERSPECTIVEPresenting Author: Zanfina Ademi, Monash University, Melbourne, VIC, Australia

Best Student Podium Research Presentations

CC4: COST-EFFECTIVENESS ANALYSIS OF PERTUZUMAB WITH TRASTUZUMAB AND CHEMOTHERAPY COMPARED TO TRASTUZUMAB AND CHEMOTHERAPY IN THE ADJUVANT TREATMENT FOR PATIENTS WITH HER2-POSITIVE EARLY BREAST CANCER AT HIGH RISK OF RECURRENCE IN CHINA
Presenting Author: Xin Guan, China Pharmaceutical University, Nanjing, China

IN1: BREAK THE BRAKES: BRAKES AND INCITEMENTS TO INFLUENZA VACCINATION, A MEDICAL RESIDENTS-CENTERED SURVEY
Presenting Author: Louis Bertin, Paris-Saclay University, Chatenay-Malabry, France

CC2: ECONOMIC ASSESSMENT OF A HIGH DOSE VERSUS A STANDARD DOSE INFLUENZA VACCINE IN THE US VETERAN POPULATION: ESTIMATING THE IMPACT ON HOSPITALIZATION COST FOR CARDIOVASCULAR AND RESPIRATORY DISEASE
Presenting Author: Rob van Aalst, Sanofi Pasteur, Swiftwater, PA, USA

Best New Investigator Podium Research Presentations

CV4: HOSPITALIZED WITH STROKE AT THE WEEKEND: ARE THERE HIGHER RISK OF EARLY DEATH AND HIGHER COSTS?
Presenting Author: Marco Ghiani, IPAM, University of Wismar, Wismar, Germany

HT1: DOES HIV COINFECTION AFFECT HCV REIMBURSEMENT DECISIONS?
Presenting Author: Nafkote Gizaw, Context Matters (a Decision Resources Group company), Jersey City, NJ, USA

RE4: IS MARKET ACCESS FOR ONCOLOGY TREATMENTS EASIER IN ENGLAND THAN FOR NON-ONCOLOGY TREATMENTS? AN ANALYSIS OF NICE SINGLE TECHNOLOGY APPRAISALS FROM 2017-2019
Presenting Author: Fatima Chunara, Remap Consulting, Alderley Edge, CHE, UK